Healthcare & Life Sciences
Oxford Biomedica
United Kingdomwww.oxfordbiomedica.co.uk
activeseries-c-plus
series-c-plus
Stage
1995
Founded
2
Investors
About
Oxford Biomedica is a gene and cell therapy company that develops and manufactures lentiviral vectors for use in personalized medicines and immunotherapies.
Explore Oxford Biomedica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.